These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22404218)

  • 1. Sulfasalazine for brain cancer fits.
    Sontheimer H; Bridges RJ
    Expert Opin Investig Drugs; 2012 May; 21(5):575-8. PubMed ID: 22404218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.
    Chung WJ; Sontheimer H
    J Neurochem; 2009 Jul; 110(1):182-93. PubMed ID: 19457125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate release by primary brain tumors induces epileptic activity.
    Buckingham SC; Campbell SL; Haas BR; Montana V; Robel S; Ogunrinu T; Sontheimer H
    Nat Med; 2011 Sep; 17(10):1269-74. PubMed ID: 21909104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
    Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
    PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
    Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
    Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema.
    Sehm T; Fan Z; Ghoochani A; Rauh M; Engelhorn T; Minakaki G; Dörfler A; Klucken J; Buchfelder M; Eyüpoglu IY; Savaskan N
    Oncotarget; 2016 Jun; 7(24):36021-36033. PubMed ID: 27074570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
    Sleire L; Skeie BS; Netland IA; Førde HE; Dodoo E; Selheim F; Leiss L; Heggdal JI; Pedersen PH; Wang J; Enger PØ
    Oncogene; 2015 Dec; 34(49):5951-9. PubMed ID: 25798841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
    Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
    Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel analogs of sulfasalazine as system x
    Patel D; Kharkar PS; Gandhi NS; Kaur E; Dutt S; Nandave M
    Drug Dev Res; 2019 Sep; 80(6):758-777. PubMed ID: 31199023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine glutamate signaling promotes glioma cell invasion.
    Lyons SA; Chung WJ; Weaver AK; Ogunrinu T; Sontheimer H
    Cancer Res; 2007 Oct; 67(19):9463-71. PubMed ID: 17909056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. System X
    Nehser M; Dark J; Schweitzer D; Campbell M; Zwicker J; Hitt DM; Little H; Diaz-Correa A; Holley DC; Patel SA; Thompson CM; Bridges RJ
    Neurochem Res; 2020 Jun; 45(6):1375-1386. PubMed ID: 31754956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.
    Robert SM; Buckingham SC; Campbell SL; Robel S; Holt KT; Ogunrinu-Babarinde T; Warren PP; White DM; Reid MA; Eschbacher JM; Berens ME; Lahti AC; Nabors LB; Sontheimer H
    Sci Transl Med; 2015 May; 7(289):289ra86. PubMed ID: 26019222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
    Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
    Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
    Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications].
    Blecic S; Rynkowski M; De Witte O; Lefranc F
    Bull Cancer; 2013 Sep; 100(9):829-35. PubMed ID: 23883552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. xCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization.
    Savaskan NE; Eyüpoglu IY
    Ann Anat; 2010 Sep; 192(5):309-13. PubMed ID: 20801625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines.
    Pham AN; Blower PE; Alvarado O; Ravula R; Gout PW; Huang Y
    J Pharmacol Exp Ther; 2010 Mar; 332(3):949-58. PubMed ID: 20007406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
    Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model.
    Haryu S; Saito R; Jia W; Shoji T; Mano Y; Sato A; Kanamori M; Sonoda Y; Sampetrean O; Saya H; Tominaga T
    J Neurooncol; 2018 Jan; 136(1):23-31. PubMed ID: 28929335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.